Document is current
Any future updates will be listed below
-
Authors
Zhang, Hongliang https://orcid.org/0000-0002-3002-798X
Quintana, Julia https://orcid.org/0000-0002-5145-3590
Ütkür, Koray
Adrian, Lorenz https://orcid.org/0000-0001-8205-0842
Hawer, Harmen
Mayer, Klaus
Gong, Xiaodi https://orcid.org/0000-0003-0104-506X
Castanedo, Leonardo
Schulten, Anna https://orcid.org/0000-0003-3720-4325
Janina, Nadežda https://orcid.org/0000-0002-0162-9340
Peters, Marcus https://orcid.org/0000-0003-1850-2845
Wirtz, Markus https://orcid.org/0000-0001-7790-4022
Brinkmann, Ulrich https://orcid.org/0000-0002-5558-0212
Schaffrath, Raffael https://orcid.org/0000-0001-9484-5247
Krämer, Ute https://orcid.org/0000-0001-7870-4508
-
Funding
Funding for this research was provided by:
Deutsche Forschungsgemeinschaft (SPP1927)
Deutsche Forschungsgemeinschaft (235736350 WI 3560-2)
Deutsche Forschungsgemeinschaft (Scha750/21-1)
Deutsche Forschungsgemeinschaft (SPP1927)
- License Information
-
More Information
Article History
Received: 11 January 2021
Accepted: 30 June 2022
First Online: 11 July 2022
Competing interests
: K.M. and U.B. are employed by Roche which has an interest in the diagnosis and treatment of human diseases, and they are co-inventors on patent applications related to diphthamide analyses in oncology. The remaining authors declare no competing interests.
